Most of what we understand about the safety and harms of different medicines emerges from published drug trials in the peer-reviewed literature, which is often unduly influenced by industry funding, selective reporting, and a lack of data transparency. Maryanne Demasi, Ph.D., discusses how the Statin Wars demonstrate the scope and stakes of this problem.
Read MoreWhere Is the Scientific Data Hiding?Rest Day
Post thoughts to comments.